Blockonomi

Blockonomi

Blockonomi is a fast growing publication at the intersection of finance and technology. It provides unbiased reporting and detailed tutorials, helping readers understand the complex world of the digital economy and fintech innovation.

Articoli di Blockonomi

Adidas (ADS) Stock Plunges 8% Following Disappointing 2026 Profit Forecast

Adidas (ADS) Stock Plunges 8% Following Disappointing 2026 Profit Forecast

Adidas (ADS) stock dropped 8% after projecting €2.3B operating profit for 2026, below €2.72B consensus, citing €400M tariff and currency headwinds. The post Adidas

Nuburu (BURU) Stock Plunges 40% Following Dilutive Offering and Defense Partnership

Nuburu (BURU) Stock Plunges 40% Following Dilutive Offering and Defense Partnership

Nuburu (BURU) stock crashes 40% after dilutive $12M offering, reverse split, and Maddox Defense JV announcement. Revenue falls 98% to $10K. The post Nuburu (BURU

Novo Nordisk (NVO) Stock Jumps 3% as FDA Cracks Down on Telehealth GLP-1 Advertisers

Novo Nordisk (NVO) Stock Jumps 3% as FDA Cracks Down on Telehealth GLP-1 Advertisers

Novo Nordisk (NVO) stock gained 3% after FDA issued warning letters to 30 telehealth firms over false claims about compounded semaglutide and tirzepatide drugs.

ServiceNow (NOW) Stock Jumps 3.7% as Dip Buyers Return

ServiceNow (NOW) Stock Jumps 3.7% as Dip Buyers Return

ServiceNow (NOW) stock climbed 3.7% to $113.44 on Tuesday after announcing new AI products and securing a telecom deal with NTT DOCOMO and StarHub. The post ServiceNow

Wix.com (WIX) Stock: Q4 2025 Results Show Earnings Strength Despite Revenue Shortfall

Wix.com (WIX) Stock: Q4 2025 Results Show Earnings Strength Despite Revenue Shortfall

Wix (WIX) stock Q4 2025 results: EPS beats at $1.81 vs $1.42 estimate, revenue misses at $524.3M, Base44 achieves $100M ARR, $250M funding secured. The post Wix

Moderna (MRNA) Stock Surges Following Historic $950M Patent Settlement

Moderna (MRNA) Stock Surges Following Historic $950M Patent Settlement

Moderna (MRNA) stock jumped 8.7% after announcing a $950M patent settlement with Arbutus and Genevant, the largest pharma patent deal ever recorded. The post Moderna

X Implements 90-Day Revenue Ban for Unlabeled AI-Generated War Content

X Implements 90-Day Revenue Ban for Unlabeled AI-Generated War Content

X enforces 90-day monetization suspension for creators posting undisclosed AI-generated war videos, connecting transparency to revenue access. The post X Implements

CrowdStrike (CRWD) Stock Surges After Strong Q4 Earnings Beat

CrowdStrike (CRWD) Stock Surges After Strong Q4 Earnings Beat

CrowdStrike (CRWD) stock rallies after beating Q4 estimates with $1.31B revenue and $1.12 EPS. ARR reaches $5.25B with 23.8% YoY growth. The post CrowdStrike (CRWD

Micron (MU) Stock Plunges 8%: A Strategic Entry Point for Investors?

Micron (MU) Stock Plunges 8%: A Strategic Entry Point for Investors?

Micron (MU) stock fell 8% Tuesday on geopolitical fears. Analysts still rate it Strong Buy with targets up to $550 ahead of March 18 earnings. Is it a buy? The

Paraguay’s ANDE Signs MoU with Morphware to Launch First Government-Led Bitcoin Mining Program

Paraguay’s ANDE Signs MoU with Morphware to Launch First Government-Led Bitcoin Mining Program

TLDR: Paraguay’s ANDE signed an MoU with Morphware to launch the country’s first government-led Bitcoin mining program. Around 1,500 machines seized from illegal